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SS18.
Ruptured Abdominal Aortic Aneurysm: The Harborview Experience-
Part 2
Benjamin W Starnes, Elina Quiroga, Nam T. Tran, Thomas Hatsukami,
Mark Meissner, Ted Kohler, Michael Sobel. University of Washington,
Seattle, WA
Objectives: Our institution treats between 30 and 50 patients per year
with ruptured abdominal aortic aneurysm (rAAA) and our overall 30-day
mortality between 2002 and 2007 averaged 60%. We sought to evaluate the
effect on mortality of the implementation of an algorithm to manage these
patients with a preference for endovascular aneurysm repair (EVAR) when
feasible.
Methods: Patients presenting with rAAA between July 1, 2002 and
June 30, 2007 served as retrospective controls. The treatment group con-
sisted of patients presenting after July 1, 2007, who were treated with a
structured protocol including early proximal control with an aortic occlusion
balloon, permissive hypotension, and endovascular repair when possible.
The primary outcome measure was 30-day mortality. Data were analyzed
using Chi Square and Fisher’s Exact Test where appropriate.
Results: The 30-day mortality for the 131 control patients was 60%.
After implementation of the protocol, 50 patients with rAAAweremanaged.
Eighteen (36%) underwent successful EVAR, and twenty-eight (46%) un-
derwent open repair. Four patients (8%) received comfort care only. Three
patients in the EVAR group (17%) and thirteen patients in the open group
(46%) died during the follow up period for an overall 30-day mortality rate
of 35% (p0.006 vs 60% of controls). There was no difference in the
incidence of hypotension on presentation (SBP80mmHg) between con-
trol (65%) and treatment (61%) groups. In the treatment group, 28/46
(61%) presented with hypotension. The incidence of hypotension between
open and EVAR patients did not differ in the treatment group. Average
transfusion requirement for those undergoing EVAR was 1 unit (0-13) and
for open repair, 8 units (0-19). The difference in transfusion requirement
amongst survivors in each group was not different (p 0.06).
Conclusions: An algorithm using early proximal aortic control with a
balloon catheter, permissive hypotension, and endovascular repair when
possible reduced rAAA mortality by 40% (absolute risk reduction of 25%).
Using this approach in a large, urban hospital, the majority of patients
presenting with rAAA survived. Further reduction in mortality is expected as
improvement in endovascular techniques allows treatment of more patients
with complex aortic anatomy.
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Implications of Endoleaks on Aneurysm Sac Pressures Following En-
dovascular Repair of Elective and Ruptured Aortic Aneurysms
Manish Mehta, John B Taggert, Sean P Roddy, Yaron Sternbach, Paul B
Kreienberg, Ashik Desai, Philip S K Paty, Kathleen J Ozsvath, Benjamin B
Chang, Dhiraj M Shah, R Clement Darling, III. Albany Medical College,
Albany, NYPurpose: To analyze the implications of endoleaks on sac pressures
following endovascular aneurysm repair (EVAR) of elective and ruptured
abdominal aortic aneurysms (AAA).
Methods: Since 2006, 480 patients underwent EVAR and simulta-
neous placement of the cardioMEMS Endosure® wireless pressure sensor in
the excluded aneurysm sac for elective (n455, 94%) and ruptured (n25,
6%) AAA. Aneuryms sac pressures were measured prior and subsequent to
completion of stentgraft placement, at 1 month, and every 6 months
thereafter. Patients were also followed-up by CTA at 6-12 month intervals,
and evaluated for the presence of endoleaks. All patients with type I
endoleaks were treated at the time of diagnosis, patients with type II
endoleaks at 6 months without decrease in aneurysm size were treated by
coil embolization. The ratio of sac to systemic pressure was used to create a
standardized pressure index for systolic pressures (SPI), diastolic pressures
(DPI), mean (MPI), and pulse pressures (PPI).
Results: At postoperative time intervals ranging from 1 day to 24
months, in patients with No Endoleak (n364, 76%), there were no
significant differences in any of the mean pressure indexes, and all indexes
decreased at 2 wks; SPI (0.09), DPI (0.2), MPI (0.12), and PPI (0.03). In
patients with Type II Endoleak (n102, 21%), there were marked elevations
in all mean pressure indexes when compared to No Endoleak group. In this
group, all indexes were higher than in patients without endoleak up to 6
months; SPI (0.30), DPI (0.46), MPI (0.38), and PPI (0.2). Treatment of
Type II endoleaks lead to a significant reduction in these indexes; SPI (0.08),
DPI (0.18),MPI (0.12), and PPI (0.02). Patients with Type I endoleaks had
consistent elevation in all pressure indexes that approximated pre-exclusion
aneurysm sac pressures; SPI (0.8), DPI (1.20), MPI (0.92), and PPI (0.42)
and these indexes decreased significantly following treatment of the type I
endoleaks. There was no difference in sac pressures in any group when
comparing EVAR for elective vs. ruptured AAA.
Conclusions: Presence of Type I and II endoleaks can be predicted on
by evaluating aneurysm sac pressures; the DPI and MPI are significantly
elevated in presence of Type I and II endoleaks. Successful treatment of
endoleaks can be predicted by decrease in aneurysm sac pressures.
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Asymptomatic Perioperative Myocardial Damage is Associated with
Poor Long-term Outcome after Vascular Surgery
Olaf Schouten1, Tamara A Winkel1, Gijs MJM Welten1, Hero van Urk1,
Hence JMVerhagen1, Jeroen J. Bax2, Don Poldermans1. 1ErasmusMedical
Center Rotterdam, Rotterdam, Netherlands; 2Leiden University Medical
Center, Leiden, Netherlands
Background: Cardiac troponin T (cTnT) release is a sensitive marker
for myocardial injury and occurs frequently after vascular surgery. However,
the prognosis of cTnT elevations without clinical symptoms and/or new
electrocardiographic changes (asymptomatic cTnT release) is unknown.
Aim: To assess the long-term prognosis of vascular surgery patients
who experience perioperative asymptomatic myocardial damage.
Methods:A total of 1545 patients undergoing elective vascular surgery
were enrolled. Baseline characteristics and medication were noted. Routine
sampling of cTnT and ECG recording was performed on day 1, 3, and 7 after
surgery and at the day of discharge. Elevated cTnT was defined as serum
concentrations  0.01 ng/ml. The mean follow-up was 3.7 years and
mortality was noted.
Results:A total of 213 (14%) patients experienced asymptomatic cTnT
release, median 0.08 ng/ml (IQR 0.04-0.20 ng/ml), while 71 (5%) patients
had symptomatic cTnT release. During follow-up 304 patients (20%) died.
Mortality was higher in patients with asymptomatic cTnT release compared
to patients without cTnT release (13% vs. 40%; p0.001, figure). After
adjustment for risk factors and type and site of surgery, the association
between asymptomatic elevated cTnT levels and increased late mortality
persisted (adjusted HR 2.3; 95% CI 1.8-3.0) and risk increased with higher
cTnT levels (HR 1.64 for every 0.10 ng/ml increase, p0.02). Elevated
cTnT had prognostic value irrespective of baseline creatinine value or renal
dysfunction after surgery.
Conclusions: Asymptomatic cTnT release, without clinical symptoms
or new ECG changes, is associated with an increased long-term mortality in
patients undergoing vascular surgery.
